Molecular Aspects in Chronic Lymphocytic Leukemia patients with Autoimmune Cytopenias: single center experience
Objective: Autoimmune cytopenia's, particularly autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP), complicate up to 25% of chronic lymphocytic leukemia (CLL) patients. Their occurrence correlates with a more aggressive disease. AIHA and ITP are more frequently found in patien...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-10-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137922013608 |
| _version_ | 1811204838103449600 |
|---|---|
| author | Sanja Trajkova Nevenka Ridova Marija Popova Labacevska Aleksandra Pivkova Veljanovska Simona Stojanovska Dushko Dukovski Milche Cvetanoski Lazar Cadievski Bozidar Kocoski Irina Panovska Stavridis |
| author_facet | Sanja Trajkova Nevenka Ridova Marija Popova Labacevska Aleksandra Pivkova Veljanovska Simona Stojanovska Dushko Dukovski Milche Cvetanoski Lazar Cadievski Bozidar Kocoski Irina Panovska Stavridis |
| author_sort | Sanja Trajkova |
| collection | DOAJ |
| description | Objective: Autoimmune cytopenia's, particularly autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP), complicate up to 25% of chronic lymphocytic leukemia (CLL) patients. Their occurrence correlates with a more aggressive disease. AIHA and ITP are more frequently found in patients with unfavorable biological risk factors for CLL. B lymphocytes at CLL are responsible of pathogenic mechanisms, involving aberrant antigen presentation and cytokine production. The aim of this study was evaluation of autoimmune cytopenia's in chronic lymphocytic leukemia patients from Republic of North Macedonia in correlation with genetic structure of pathologic B lymphocyte. Methodology: This is a retrospective study of patients with CLL, diagnosed and followed in the period between January 2011 and January 2021. Individual data from 100 treatment naïve CLL patients were analyzed, and mutational status and configuration of IGHV-IGHD-IGHJ rearrangements and genetics were analyzed using reverse transcriptase– polymerase chain reaction (RT-PCR) and sequencing methodology at the center for bimolecular pharmaceutical analyses, faculty of pharmacy, Skopje, Republic of North Macedonia. Results: Our evaluation have shown that 10% of CLL patients had AIHA and 4% had ITP. Most of the patients with autoimmune cytopenias had unmuteted IGHV genes. The most frequently expressed IGHV subgroup was IGHV1-69 (71%), followed by IGHV3-13 and IGHV4-4 (14%). The genetic results presented unfavorable cytogenetics with 11q deletions and NOTHCH mutation. Conclusion: The results of our study are consistent with published studies with specific molecular signature. |
| first_indexed | 2024-04-12T03:20:27Z |
| format | Article |
| id | doaj.art-29d731c23fe84acc90a95127e9ad6a4f |
| institution | Directory Open Access Journal |
| issn | 2531-1379 |
| language | English |
| last_indexed | 2024-04-12T03:20:27Z |
| publishDate | 2022-10-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Hematology, Transfusion and Cell Therapy |
| spelling | doaj.art-29d731c23fe84acc90a95127e9ad6a4f2022-12-22T03:49:54ZengElsevierHematology, Transfusion and Cell Therapy2531-13792022-10-0144S27Molecular Aspects in Chronic Lymphocytic Leukemia patients with Autoimmune Cytopenias: single center experienceSanja Trajkova0Nevenka Ridova1Marija Popova Labacevska2Aleksandra Pivkova Veljanovska3Simona Stojanovska4Dushko Dukovski5Milche Cvetanoski6Lazar Cadievski7Bozidar Kocoski8Irina Panovska Stavridis9University St.Cyril and Methodius, Skopje, Macedonia University Clinic for Hematology, Skopje, MacedoniaUniversity St.Cyril and Methodius, Skopje, Macedonia University Clinic for Hematology, Skopje, MacedoniaUniversity St.Cyril and Methodius, Skopje, Macedonia University Clinic for Hematology, Skopje, MacedoniaUniversity St.Cyril and Methodius, Skopje, Macedonia University Clinic for Hematology, Skopje, MacedoniaUniversity St.Cyril and Methodius, Skopje, Macedonia University Clinic for Hematology, Skopje, MacedoniaUniversity St.Cyril and Methodius, Skopje, Macedonia University Clinic for Hematology, Skopje, MacedoniaUniversity St.Cyril and Methodius, Skopje, Macedonia University Clinic for Hematology, Skopje, MacedoniaUniversity St.Cyril and Methodius, Skopje, Macedonia University Clinic for Hematology, Skopje, MacedoniaUniversity St.Cyril and Methodius, Skopje, Macedonia University Clinic for Hematology, Skopje, MacedoniaUniversity St.Cyril and Methodius, Skopje, Macedonia University Clinic for Hematology, Skopje, MacedoniaObjective: Autoimmune cytopenia's, particularly autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP), complicate up to 25% of chronic lymphocytic leukemia (CLL) patients. Their occurrence correlates with a more aggressive disease. AIHA and ITP are more frequently found in patients with unfavorable biological risk factors for CLL. B lymphocytes at CLL are responsible of pathogenic mechanisms, involving aberrant antigen presentation and cytokine production. The aim of this study was evaluation of autoimmune cytopenia's in chronic lymphocytic leukemia patients from Republic of North Macedonia in correlation with genetic structure of pathologic B lymphocyte. Methodology: This is a retrospective study of patients with CLL, diagnosed and followed in the period between January 2011 and January 2021. Individual data from 100 treatment naïve CLL patients were analyzed, and mutational status and configuration of IGHV-IGHD-IGHJ rearrangements and genetics were analyzed using reverse transcriptase– polymerase chain reaction (RT-PCR) and sequencing methodology at the center for bimolecular pharmaceutical analyses, faculty of pharmacy, Skopje, Republic of North Macedonia. Results: Our evaluation have shown that 10% of CLL patients had AIHA and 4% had ITP. Most of the patients with autoimmune cytopenias had unmuteted IGHV genes. The most frequently expressed IGHV subgroup was IGHV1-69 (71%), followed by IGHV3-13 and IGHV4-4 (14%). The genetic results presented unfavorable cytogenetics with 11q deletions and NOTHCH mutation. Conclusion: The results of our study are consistent with published studies with specific molecular signature.http://www.sciencedirect.com/science/article/pii/S2531137922013608 |
| spellingShingle | Sanja Trajkova Nevenka Ridova Marija Popova Labacevska Aleksandra Pivkova Veljanovska Simona Stojanovska Dushko Dukovski Milche Cvetanoski Lazar Cadievski Bozidar Kocoski Irina Panovska Stavridis Molecular Aspects in Chronic Lymphocytic Leukemia patients with Autoimmune Cytopenias: single center experience Hematology, Transfusion and Cell Therapy |
| title | Molecular Aspects in Chronic Lymphocytic Leukemia patients with Autoimmune Cytopenias: single center experience |
| title_full | Molecular Aspects in Chronic Lymphocytic Leukemia patients with Autoimmune Cytopenias: single center experience |
| title_fullStr | Molecular Aspects in Chronic Lymphocytic Leukemia patients with Autoimmune Cytopenias: single center experience |
| title_full_unstemmed | Molecular Aspects in Chronic Lymphocytic Leukemia patients with Autoimmune Cytopenias: single center experience |
| title_short | Molecular Aspects in Chronic Lymphocytic Leukemia patients with Autoimmune Cytopenias: single center experience |
| title_sort | molecular aspects in chronic lymphocytic leukemia patients with autoimmune cytopenias single center experience |
| url | http://www.sciencedirect.com/science/article/pii/S2531137922013608 |
| work_keys_str_mv | AT sanjatrajkova molecularaspectsinchroniclymphocyticleukemiapatientswithautoimmunecytopeniassinglecenterexperience AT nevenkaridova molecularaspectsinchroniclymphocyticleukemiapatientswithautoimmunecytopeniassinglecenterexperience AT marijapopovalabacevska molecularaspectsinchroniclymphocyticleukemiapatientswithautoimmunecytopeniassinglecenterexperience AT aleksandrapivkovaveljanovska molecularaspectsinchroniclymphocyticleukemiapatientswithautoimmunecytopeniassinglecenterexperience AT simonastojanovska molecularaspectsinchroniclymphocyticleukemiapatientswithautoimmunecytopeniassinglecenterexperience AT dushkodukovski molecularaspectsinchroniclymphocyticleukemiapatientswithautoimmunecytopeniassinglecenterexperience AT milchecvetanoski molecularaspectsinchroniclymphocyticleukemiapatientswithautoimmunecytopeniassinglecenterexperience AT lazarcadievski molecularaspectsinchroniclymphocyticleukemiapatientswithautoimmunecytopeniassinglecenterexperience AT bozidarkocoski molecularaspectsinchroniclymphocyticleukemiapatientswithautoimmunecytopeniassinglecenterexperience AT irinapanovskastavridis molecularaspectsinchroniclymphocyticleukemiapatientswithautoimmunecytopeniassinglecenterexperience |